Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023
2023-04-20 08:00
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023
2023-04-20 08:00
University of Technology Sydney researchers develop ground-breaking heart failure treatment using 3D-printed heart tissue
2023-04-20 06:00
uLab® Launches the Orthodontics Industry's First Suite of Practice-Branded Packaging Options
2023-04-19 21:11
500 women join Australia's landmark maternity medical device study
2023-04-19 21:08
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
2023-04-19 21:00
Concord Medical Files 2022 Annual Report on Form 20-F
2023-04-19 20:30
Health In Tech to Showcase Cutting-Edge Benefits Solutions at the National Association of Benefits and Insurance Professionals (NABIP)-TX 2023 Conference as a Corporate Sponsor
2023-04-19 20:30
China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering
2023-04-19 20:30
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
2023-04-19 20:05
Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
2023-04-19 14:00
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use
2023-04-19 11:05
HOYA Group PENTAX Medical Singapore Pte. Ltd. Wins the Endoscopy Product Innovation of the Year Award at the Healthcare Asia Medtech Awards 2023
2023-04-19 11:00
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses
2023-04-19 08:45
AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting
2023-04-19 08:29
Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
2023-04-19 08:12
Agilis Robotics conducts first live animal trial for GI indication, targeting 510(k) clearance by 2025 to transform endoscopic surgery
2023-04-19 07:00
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting
2023-04-19 07:00
Chamlion completed 236 million yuan in Series B fundraising, building a new eco-system of digital dentistry
2023-04-18 21:10
Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial
2023-04-18 21:00
1
209
210
211
212
213
970